康師傅(00322.HK)逆市曾挫逾13% 去年純利及派息按年均降三成
藍籌康師傅(00322.HK)去年純利及派息按年均降30.8%,今早股價逆市低開逾5%報13.44元欠承接,進一步跌破250天線(12.82元)後,跌幅持續擴至13.8%,報12.22元,創逾三個月低。美銀證券下調康師傅投資評級,由「買入」降至「中性」,將目標價由16.2元降至15元,指業績符預期,但公司前景指引疲弱,並指派息亦令人失望。
康師傅昨天收市公布,去年純利按年減少30.8%至26.32億元人民幣(下同),每股基本盈利46.73分,末期及特別股息合共派46.72分,較2021年合共派67.52分,減少30.8%。期內,總收入按年升6.3%至87.17億元;毛利按年升近2%報228.99億元,整體毛利率按年降1.3個百分點至29.09%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.